cT1a肾肿块小于2cm与2cm及以上机器人部分肾切除术倾向性评分匹配比较
单中心倾向性评分1:1匹配比较cT1a肾肿块小于2cm与2cm及以上行机器人部分肾切除术的围手术期、病理和功能结局。共分析524例(各262例),小于2cm组手术时间、出血量、缺血时间及术中输血率更低,早期肾功能更优,但恶性肿瘤发生率更低。
要点
- 小于2cm肾肿块行机器人部分肾切除术缺血时间更短(14.3 vs 21.5分钟)。
- 小于2cm组术中输血率0% vs 2.7%,早期eGFR更高。
- 大于2cm组恶性肿瘤比例更高(85.9% vs 74.8%),切缘阳性无差异。
核心结论
- 机器人部分肾切除术对小于2cm肾肿块倾向于低并发症治疗方式,仍可作为特定患者的选择。
研究设计与样本
- 单中心回顾性队列,利用2007年1月至2017年1月机构机器人部分肾切除术数据库,按年龄、性别、种族、BMI、Charlson共病指数、吸烟、糖尿病、高血压、高脂血症、ASA评分、eGFR、CKD分期和R.E.N.A.L.评分进行1:1倾向性评分匹配,分析524例(小于2cm组262例,2cm及以上组262例)。
主要发现
- 小于2cm组手术时间、出血量、缺血时间(均值±SD 14.3±9.58 vs 21.5±9.51分钟,p<0.001)和术中输血率(0% vs 2.7%,p=0.015)显著更低。
- 小于2cm组术后第1天eGFR更高(均值83.1±21.3 vs 76.6±22.0 mg/ml/1.73 m,p=0.001),肾实质保留更多(均值89.9%±9.45% vs 83.6%±8.20%,p<0.001)。
- 小于2cm组术后并发症发生率有更低趋势(13.5% vs 19.5%,p=0.080)。
- 大于2cm组恶性肿瘤发生率更高(85.9% vs 74.8%,p=0.002),两组切缘阳性率无差异。
临床怎么用
- 对于小于2cm的cT1a肾肿块,机器人部分肾切除术围手术期风险较低,可作为主动监测之外的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We performed a single center evaluation to compare perioperative, pathological and functional outcomes of robotic partial nephrectomy of T1a renal masses less than vs greater than 2 cm. MATERIALS AND METHODS: Propensity score 1:1 matching of queried patients was performed using the institutional robotic partial nephrectomy database from January 2007 to January 2017. Matching was done by patient age, gender, race, body mass index, the Charlson comorbidity index, smoking status, diabetes, hypertension, hyperlipidemia, ASA® (American Society of Anesthesiologists®) score, estimated glomerular filtration rate, chronic kidney disease stage and R.E.N.A.L. (radius, exophytic/endophytic properties, nearness of tumor to collecting system or sinus, anterior/posterior, location relative to polar line and abutting main renal artery or vein) score. We analyzed the records of 524 patients, including 262 with a renal mass less than 2 cm vs 262 with a renal mass 2 cm or greater. Perioperative, pathological and functional outcomes were evaluated. RESULTS: Smaller renal masses (less than 2 cm) were associated with significantly lower operative time, blood loss, ischemia time (mean ± SD 14.3 ± 9.58 vs 21.5 ± 9.51 minutes, p <0.001) and intraoperative transfusions (0% vs 2.7%, p = 0.015). Moreover, we found superior early renal functional outcomes as assessed by the estimated glomerular filtration rate on postoperative day 1 (mean 83.1 ± 21.3 vs 76.6 ± 22.0 mg/ml/1.73 m, p = 0.001), greater parenchymal preservation (mean 89.9% ± 9.45% vs 83.6% ± 8.20%, p <0.001) and a trend toward a lower rate of postoperative complications (13.5% vs 19.5%, p = 0.080). A higher incidence of malignancy was found in larger tumors (85.9% vs 74.8%, p = 0.002) but no difference was recorded in positive surgical margins. CONCLUSIONS: Robotic partial nephrectomy tends to be a low morbidity treatment modality for renal masses less than 2 cm. Although active surveillance is a common option for such tumors, robotic partial nephrectomy remains an alternative in select patients.
引用
- Bertolo R, Garisto J, Dagenais J, et al. cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes. J Urol. 2019. PMID: 30100402. doi:10.1016/j.juro.2018.06.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。